News Archive: Health

Title Category Date
MARKET SNAPSHOT: Stock Market Books Weekly, Daily Gain As Tech And Energy Sectors Rally Health 06-23-17
MARKET SNAPSHOT: Stock Market Edges Higher As Tech, Energy Sectors Lead Gains Health 06-23-17
MARKET SNAPSHOT: Stock Market Climbs As Energy, Tech Sectors Stage A Rally Health 06-23-17
MARKET SNAPSHOT: Stock Market Edges Up As Nasdaq Aims For Weekly Win Health 06-23-17
Samsung Makes Play for Drug Market With Version of Humira -- Update Health 06-23-17
MARKET SNAPSHOT: Stock Market Hunts For Catalyst, While Nasdaq Aims For Weekly Win Health 06-23-17
MARKET SNAPSHOT: Stock Futures Hunt For A Catalyst, With Nasdaq Poised For A Weekly Win Health 06-23-17
MARKET SNAPSHOT: U.S. Stock Futures Hunt For A Catalyst, With Nasdaq Poised For A Weekly Win Health 06-23-17
Samsung Makes Big Play in Drug Market With Cheaper Version of Blockbuster Humira Health 06-23-17
MARKET SNAPSHOT: U.S. Stock Futures Hunt For A Catalyst, With Nasdaq Poised For A Weekly Win Health 06-23-17
Theranos, Walgreens to Settle -- WSJ Health 06-22-17
Theranos, Walgreens Reach Deal to Settle Lawsuit--Update Health 06-21-17
Hot Stocks to Watch in the U.S. and Canada Health 06-20-17
EUROPE MARKETS: European Stocks Climb, With French Market Boosted In Wake Of Parliamentary Elections Health 06-19-17
EUROPE MARKETS: European Stocks Climb, With French Market Higher After Parliamentary Elections Health 06-19-17
EUROPE MARKETS: European Stocks Climb, With French Market Higher After Parliamentary Elections Health 06-19-17
Valeant to Sell iNova Unit In $930 Million Transaction -- WSJ Health 06-09-17
EUROPE MARKETS: European Stocks Fall, Finishing At Lowest Level In Almost 3 Weeks Health 06-06-17
EUROPE MARKETS: European Stocks Set For 1-week Low As Caution Sets In Health 06-06-17
Alexion stock rises 1.4% after naming new executives -- MarketWatch Health 06-02-17
Bluebird Bio stock jumps 7% after Maxim Group upgrades to buy -- MarketWatch Health 06-02-17
Merck reports positive results for late-stage trial comparing its Keytruda against Bristol-Myers' Yervoy -- MarketWatch Health 06-02-17
Bristol-Myers Squibb reports data from phase 1/2 trial for cancers associated with HPV -- MarketWatch Health 06-02-17
Content Partners